SPDR S&P BIOTECH ETF (XBI)
NYSEARCA: XBI · Real-Time Price · USD
108.39
+0.83 (0.77%)
Oct 24, 2025, 3:45 PM EDT - Market open
XBI Holdings Information
XBI is an equity ETF with a total of 136 individual holdings. The top holdings are CRISPR Therapeutics AG stock at 2.18%, Revolution Medicines at 2.02%, Exact Sciences at 2.01%, Natera at 1.95%, and Ionis Pharmaceuticals at 1.89%.
Total Holdings
25
Top 10 Percentage
19.23%
Asset Class
Equity
ETF Category
Health
Assets
6.72B
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | 2.18% |
| 2 | RVMD | Revolution Medicines, Inc. | 2.02% |
| 3 | EXAS | Exact Sciences Corporation | 2.01% |
| 4 | NTRA | Natera, Inc. | 1.95% |
| 5 | IONS | Ionis Pharmaceuticals, Inc. | 1.89% |
| 6 | INSM | Insmed Incorporated | 1.86% |
| 7 | VRTX | Vertex Pharmaceuticals Incorporated | 1.84% |
| 8 | MRNA | Moderna, Inc. | 1.83% |
| 9 | ABBV | AbbVie Inc. | 1.83% |
| 10 | UTHR | United Therapeutics Corporation | 1.82% |
| 11 | ROIV | Roivant Sciences Ltd. | 1.79% |
| 12 | BIIB | Biogen Inc. | 1.78% |
| 13 | AMGN | Amgen Inc. | 1.78% |
| 14 | GILD | Gilead Sciences, Inc. | 1.78% |
| 15 | RNA | Avidity Biosciences, Inc. | 1.77% |
| 16 | REGN | Regeneron Pharmaceuticals, Inc. | 1.76% |
| 17 | INCY | Incyte Corporation | 1.75% |
| 18 | NBIX | Neurocrine Biosciences, Inc. | 1.72% |
| 19 | BBIO | BridgeBio Pharma, Inc. | 1.72% |
| 20 | EXEL | Exelixis, Inc. | 1.71% |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 1.70% |
| 22 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.67% |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.67% |
| 24 | AKRO | Akero Therapeutics, Inc. | 1.52% |
| 25 | HALO | Halozyme Therapeutics, Inc. | 1.50% |
As of Oct 23, 2025